This is a randomized, double-blind, placebo-controlled study designed to evaluate the
efficacy and safety of 2 fixed doses of lurasidone (20 mg/day and 60 mg/day) for 6 weeks
compared with placebo in pediatric and adolescent subjects with irritability associated with
autistic disorder who reside in the community setting.